We are live on
!
Find out more
AYLA
Ayala Pharmaceuticals, Inc. Common Stock
AYLA
AYLA
Delisted
AYLA was delisted on the 18th of January, 2023.
15 hedge funds and large institutions have $4.57M invested in Ayala Pharmaceuticals, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
7% more funds holding
Funds holding: 14 → 15 (+1)
76% less capital invested
Capital invested by funds: $18.8M → $4.57M (-$14.3M)
83% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 6
Holders
15
Holders Change
+1
Holders Change %
+7.14%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
1
Reduced
6
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Citigroup
New York
|
+$930K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$310K |
| 3 |
Renaissance Technologies
New York
|
+$87K |
| 4 |
CL
CSS LLC
Chicago,
Illinois
|
+$72.8K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$5.68K |
Top Sellers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$2.58M |
| 2 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$995K |
| 3 |
RG
Redmile Group
San Francisco,
California
|
-$248K |
| 4 |
SCM
Sio Capital Management
New York
|
-$240K |
| 5 |
Millennium Management
New York
|
-$95.8K |
